Our Mission and Vision

Our mission and passion is to expand what’s possible in endosurgery. We strive to discover new ways to perform even the most complex procedures safely, efficiently, and less invasively—reducing risk, saving time, and enhancing the lives of both physicians and patients.

Company Profile

Founded in December 2014, Lumendi holds a worldwide exclusive license to certain intellectual property developed by Minimally Invasive New Technologies (MINT), a joint program of Weill Cornell Medical College and NewYork-Presbyterian Hospital. In collaboration with MINT and other partners, Lumendi is developing devices to enable less invasive endolumenal procedures in the GI tract, primarily in the colon. These devices have the potential to replace many invasive laparoscopic and open surgical procedures currently performed in the hospital setting, and may also facilitate the performance of these procedures in the outpatient setting. We’re also working on additional less invasive techniques that can lead to better patient outcomes and make procedures easier and more comfortable for clinicians.

We partner with leaders in healthcare to understand their needs and the needs of patients and work to develop new solutions that will improve their lives.

As part of our mission to improve healthcare, Lumendi LLC. is committed to building and maintaining a culture of ethical behavior and compliance with all applicable laws, regulations, and industry standards. We have developed a Corporate Healthcare Compliance Program that is designed to comply with applicable federal and state laws. Our Compliance Program is also in line with industry standards relating to the marketing and promotion of our products. We expect all of our employees and agents to act with integrity and to adhere to our Compliance Program in the performance of their duties.

To the best of our knowledge, as of 2018, Lumendi LLC. is in compliance with our Compliance Program, as described here, and with California Health & Safety Code sections 119400 – 119402. For a copy of our Compliance Program and this written declaration of compliance, please call 203-463-2669.

Lumendi Ltd. news

Lumendi Reports First Incisionless Appendectomy Using Double-Balloon Endolumenal Interventional Platform

Contact supplier